We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
ZeptoMetrix an Antylia scientific company

Download Mobile App




Uncombable Hair Syndrome Genes Identified

By Michal Siman-Tov
Posted on 29 Nov 2016
Print article
Image: A girl with uncombable hair syndrome (Photo courtesy of the University of Bonn).
Image: A girl with uncombable hair syndrome (Photo courtesy of the University of Bonn).
Some children suffer from tangled hair that cannot be combed due to having the rare uncombable hair syndrome (UHS). Scientists have discovered that mutations in three genes encoding proteins involved in hair shaft formation lead to UHS, in Germany commonly known as Struwwelpeter Syndrome, named after a children’s storybook character.

Researchers from eight countries were involved in the study, led by the groups at University of Bonn (Bonn, Germany) and University of Toulouse (Toulouse, France).

Many parents know it is not always easy to comb children’s hair, yet with patience and nerves of steel the knots can usually be undone. In the case of UHS, brushes and combs are ineffective. Those affected have extremely frizzy, dry, generally light blonde hair with a characteristic shine, and resists attempts to tame it. These symptoms are most pronounced in childhood and then ease over time. In adulthood, the hair can more or less be styled normally.

Almost nothing has been known about the causes, particularly because the phenomenon is rare. It was described in the specialist literature for the first time in 1973; since then, around 100 cases have been documented worldwide. “However, we assume that there are much more people affected,” said Regina Betz, professor at University of Bonn, and a specialist for rare hereditary hair disorders, “Those who suffer from UHS do not necessarily seek help for this from a doctor or hospital.” It is known that the anomaly occurs more frequently in some families and thus appears to have genetic causes. “Via contact with colleagues from around the world, we managed to find 9 further children,” she said.

The scientists at Bonn sequenced all the genes of those affected, and found mutations in 3 genes involved in hair shaft formation. Two genes, PADI3 and TGM3, encode enzymes, while the third, TCHH, encodes a structural protein. In healthy hair, TCHH proteins are joined by crosslinking with very fine strands of keratin, which are responsible for hair shape and structure. During this process “PADI3 changes the hair shaft protein TCHH in such a way that the keratin filaments can adhere to it,” explained lead author Dr. Fitnat Buket Basmanav Ünalan, “The TGM3 enzyme then produces the actual link.”

Together with their University of Toulouse colleagues, the scientists at Bonn performed cell culture experiments that showed that loss-of-function mutations in any one of the three genes has fundamental effects on the structure and stability of the hair. Mice with defective PADI3 or TGM3 developed characteristic fur anomalies that were very similar to the human UHS phenotype.

“From the mutations found, a huge amount can be learned about the mechanisms involved in forming healthy hair, and why disorders sometimes occur,” said Prof. Betz, “At the same time, we can now secure the clinical diagnosis of ‘uncombable hair’ with molecular genetic methods.” Some hair anomalies are associated with severe concomitant diseases, which sometimes only become manifest in later life. However, UHS generally occurs in isolation, without other health impairments, so diagnosis can help reduce concerns about future illness. Uncombable hair may be tiresome and may also cause mental stress, said Prof. Betz, “However, those affected have no need to otherwise worry.”

The study, by Basmanav FBU et al, was published November 17, 2016, in the American Journal of Human Genetics.

Related Links:
University of Bonn
University of Toulouse
Gold Member
Fully Automated Cell Density/Viability Analyzer
BioProfile FAST CDV
Verification Panels for Assay Development & QC
Seroconversion Panels
New
Cytomegalovirus Test
NovaLisa Cytomegalovirus (CMV) IgG Test
New
Typhoid Rapid Test
OnSite Typhoid IgG/IgM Combo Rapid Test

Print article

Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.